Objective Hypertensive left ventricular hypertrophy is associated with
an increased risk of arrhythmias and mortality. However, no clinical
study has demonstrated a significant relationship between ventricular
arrhythmias and mortality in systemic hypertension. Design and methods
To evaluate the prognostic value of arrhythmogenic markers, we includ
ed, prospectively, 214 hypertensive patients aged (mean +/- SD) 59.1 /- 12.8 years, without symptomatic coronary disease, myocardial infarc
tion, systolic dysfunction or electrolyte disturbances. At inclusion,
a 12-lead electrocardiogram (ECG) with QT dispersion calculation, a 24
h Holter ECG (204 patients) with Lown classification of ventricular a
rrhythmias, echocardiography (reliable in 187 patients) and a signal-a
veraged ECG (125 patients) with ventricular late potentials were recor
ded. Results At baseline, echocardiographic left ventricular hypertrop
hy was found in 63 patients (33.7%). Non-sustained ventricular tachyca
rdia (Lown class IVb) was recorded in 33 patients (16.2%) and late pot
entials in 27 patients (21.6%). After a mean follow-up of 42.4 +/- 26.
8 months, all-cause mortality was 11.2% (24 patients); 17 patients die
d of cardiac causes (7.9%); of these, nine (4.2%) died suddenly. In un
ivariate analysis, age, Lown class IVb and a QT dispersion > 80 ms wer
e significantly related to global, cardiac and sudden death (P < 0.01)
. The left ventricular mass index was related to cardiac mortality (P
= 0.002). In multivariate analysis, only Lown class IVb was an indepen
dent predictor of global and cardiac mortality, increasing the risk of
global death 2.6-fold (95% confidence interval 1.2-6.0) and cardiac d
eath 3.5-fold (95% confidence interval 1.2-9.7). Conclusion In hyperte
nsive patients the presence of non-sustained ventricular tachycardia h
as prognostic value. (C) Rapid Science Publishers ISSN 0263-6352.